Virtus Health

Last updated
Virtus Health
Parent BGH Capital
Website www.virtushealth.com.au   OOjs UI icon edit-ltr-progressive.svg

Virtus Health is an Australian company, headquartered in Sydney, that provides assisted reproductive technology, specialist pathology and day hospital services. [1] Today, Virtus is one of the top five providers of assisted reproductive services in the world with a presence in Australia, Singapore, Ireland, the UK and Denmark. [2]

The company operates seven specialist day hospitals across Queensland, NSW, Victoria and Tasmania, supporting procedures in fertility, IVF and gynaecology, plastic and cosmetic procedures, dentistry, ophthalmology, urology, orthopaedics and general surgery.

Virtus Diagnostics was established as a separate division in 2015 and offers general pathology services as well as specialist fertility and genetic testing. [3]

Virtus Health completed a number of acquisition, including Canberra Fertility Centre in 2016, [4] IDS Pathology in 2015, [5] Rotunda IVF in 2015, [6] TasIVF in 2014 [7] IVF Sunshine Coast in 2014, [8] and Sims IVF in 2014. [9]

Virtus Health listed on the Australian Stock Exchange in June 2013. On 4 August 2022 Virtus Health was de-listed from the ASX following its acquisition by private equity firm BGH Capital. [10]

Scientific achievements

Related Research Articles

<span class="mw-page-title-main">In vitro fertilisation</span> Assisted reproductive technology procedure

In vitro fertilisation (IVF) is a process of fertilisation where an egg is combined with sperm in vitro. The process involves monitoring and stimulating a woman's ovulatory process, removing an ovum or ova from her ovaries and letting sperm fertilise them in a culture medium in a laboratory. After the fertilised egg (zygote) undergoes embryo culture for 2–6 days, it is transferred by catheter into the uterus, with the intention of establishing a successful pregnancy.

<span class="mw-page-title-main">Assisted reproductive technology</span> Methods to achieve pregnancy by artificial or partially artificial means

Assisted reproductive technology (ART) includes medical procedures used primarily to address infertility. This subject involves procedures such as in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), cryopreservation of gametes or embryos, and/or the use of fertility medication. When used to address infertility, ART may also be referred to as fertility treatment. ART mainly belongs to the field of reproductive endocrinology and infertility. Some forms of ART may be used with regard to fertile couples for genetic purpose. ART may also be used in surrogacy arrangements, although not all surrogacy arrangements involve ART. The existence of sterility will not always require ART to be the first option to consider, as there are occasions when its cause is a mild disorder that can be solved with more conventional treatments or with behaviors based on promoting health and reproductive habits.

Thomson Medical Centre Limited is a 190-bed private hospital located at Thomson Road in Singapore. The hospital specialises in gynaecology and in vitro fertilisation (IVF). Thomson Medical Centre runs a 24-hour outpatient family clinic, as well as a range of specialist clinics.

Healthscope is a for-profit Australian company which operates private hospitals, medical centres and rehabilitation hospitals. The company is headquartered on St Kilda Road, Melbourne. It operates medical/surgical hospitals and a number of psychiatric and rehabilitation hospital clinics.

<span class="mw-page-title-main">Reproductive medicine</span> Branch of medicine

Reproductive medicine is a branch of medicine concerning the male and female reproductive systems. It encompasses a variety of reproductive conditions, their prevention and assessment, as well as their subsequent treatment and prognosis.

<span class="mw-page-title-main">Human Fertilisation and Embryology Act 1990</span> United Kingdom legislation

The Human Fertilisation and Embryology Act 1990 is an Act of the Parliament of the United Kingdom. It created the Human Fertilisation and Embryology Authority which is in charge of human embryo research, along with monitoring and licensing fertility clinics in the United Kingdom.

nib Health Funds

nib Group is an Australian health care fund. It was established in 1952 to provide health insurance for workers at the BHP Newcastle Steelworks, and has since grown into a national and international operation. As of 2017, nib held an 8.3% share of the Australian private health cover market.

Sperm donation laws vary by country. Most countries have laws to cover sperm donations which, for example, place limits on how many children a sperm donor may give rise to, or which limit or prohibit the use of donor semen after the donor has died, or payment to sperm donors. Other laws may restrict use of donor sperm for in vitro fertilisation (IVF) treatment, which may itself be banned or restricted in some way, such as to married heterosexual couples, banning such treatment to single women or lesbian couples. Donated sperm may be used for insemination or as part of IVF treatment. Notwithstanding such laws, informal and private sperm donations take place, which are largely unregulated.

Fertility tourism is the practice of traveling to another country or jurisdiction for fertility treatment, and may be regarded as a form of medical tourism. A person who can become pregnant is considered to have fertility issues if they are unable to have a clinical pregnancy after 12 months of unprotected intercourse. Infertility, or the inability to get pregnant, affects about 8-12% of couples looking to conceive or 186 million people globally. In some places, rates of infertility surpass the global average and can go up to 30% depending on the country. Areas with lack of resources, such as assisted reproductive technologies (ARTs), tend to correlate with the highest rates of infertility.

Sonic Healthcare Limited is a Sydney-based, Australian company that provides laboratory services, pathology, and radiology services.

Geeta Nargund is a professor and medical doctor in the field of natural and mild IVF and Advanced Technology in Reproductive Medicine.

Partner-assisted reproduction, reception of oocytes from partner (ROPA), reciprocal IVF,shared motherhood, partner IVF or co-IVF is a method of family building that is used by couples who both possess female reproductive organs. The method uses in vitro fertilization (IVF), a method that means eggs are removed from the ovaries, fertilized in a laboratory, and then one or more of the resulting embryos are placed in the uterus to hopefully create a pregnancy. Reciprocal IVF differs from standard IVF in that two partners are involved: the eggs are taken from one partner, and the other partner carries the pregnancy. In this way, the process is mechanically identical to IVF with egg donation. Reciprocal IVF offers the highest chance for pregnancy and a lower risk of a multiple birth. Using this process ensures that each partner is a biological parent of the child. This fertility process is one way that allows lesbian and trans male couples to reproduce and both be involved in the physical process of becoming pregnant.

Simon Fishel is an English physiologist, biochemist and pioneering in vitro fertilisation (IVF) specialist.

<span class="mw-page-title-main">Julia Indichova</span>

Julia Indichova is an American reproductive healthcare activist and author. She is best known for her book Inconceivable: A Woman’s Triumph Over Despair and Statistics (2001), which was hailed by Library Journal as “an important consumer health resource…the first such book written from the patient’s point of view.” In 1997 Indichova founded FertileHeart.com, a global, patient driven community, focused on health enhancing approaches to reproductive health.

Peter C. Klatsky is a Doctor of Medicine specialized in reproductive endocrinology and infertility and an assistant professor at the Albert Einstein College of Medicine. Klatsky who is board certified in his specialty as well as in obstetrics and gynaecology, is also the Founder and CEO of Spring Fertility Management Llc, a San Francisco Bay Area fertility company. Klatsky is a member of the Council on Foreign Relations, a nonprofit think tank specializing in U.S. foreign policy and international affairs.

Joyce Harper is Professor of Reproductive Science at the Institute for Women's Health, University College London where she heads the Reproductive Science and Society group. She is director of the Embryology and PGD Academy and Global Women Connected.

Quadrant Private Equity is an Australian private equity investment firm based in Sydney, Australia. The company was founded as Quadrant Capital in 1996 by Chris Hadley. By 2022, the Managing Partner was Jonathan Pearce.

Prelude Fertility is a network of fertility clinics in the United States that offer fertility services including in vitro fertilization (IVF), egg donation, genetic testing, and egg freezing. As of 2019, the Prelude Fertility Network of clinics included 23 fertility practices and 36 locations in the U.S. and more than 60 affiliated reproductive endocrinologists.

<span class="mw-page-title-main">BGH Capital</span>

BGH Capital (BGH) is an Australian private equity company established in 2017 by Robin Bishop, Ben Gray, and Simon Harle. BGH is headquartered in Melbourne and is owned and managed by its founding partners.

Catharyn Johanna Stern is a clinical associate professor, and gynaecologist at Waverley Private Hospital in Melbourne, Victoria. She was appointed an Officer of the Order of Australia for distinguished service to gynaecology, reproductive medicine and fertility research. Stern has been a member of the Australian Medical Association (AMA) member for 23 years. Her award was for her services to gynaecology, to reproductive medicine and fertility research, and to the community.

References

  1. Binsted, Tim (23 February 2016). "Virtus Health Profit Up 7pc to $17.9m".
  2. Virtus Health to pay special dividend if BGH deadline is met (afr.com)
  3. Carlisle, James (24 September 2015). "Virtus Health's Genetic Goldmine". Share Cafe. Retrieved 25 July 2016.
  4. "Virtus Health, Australia's Largest IVF provider, Has Bought Canberra Fertility Centre for $3.5 Million". The Canberra Times. 21 May 2016. Retrieved 25 July 2016.
  5. "Virtus Health acquires IDS Pathology Laboratory". Reuters. 2 September 2015. Retrieved 25 July 2016.
  6. Gantly, Dara (9 January 2015). "Australian IVF Provider Acquires HARI Clinic". Irish Medical Times. Retrieved 25 July 2016.
  7. "Virtus Health Ltd acquires majority stake in Tasmanian IVF provider, TasIVF for $16.0 million". Reuters. 4 December 2014. Retrieved 25 July 2016.
  8. "Virtus acquires IVF Sunshine Coast". News.com.au. 3 November 2014. Retrieved 25 July 2016.
  9. Hoey, Trevor (2 July 2014). "Virtus shows thirst for growth with Sims IVF buy". Financial Review. Retrieved 25 July 2016.
  10. "Removal from Official List" (PDF). ASX Announcements.
  11. "Leeandra Wilton". Bloomberg. Retrieved 25 July 2016.